End-Stage Renal Disease Requiring Haemodialysis
13
6
8
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.7%
1 terminated out of 13 trials
66.7%
-19.9% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (13)
Effects of Supervised Exercise Training on Erythrocyte Deformability in Hemodialysis Patients
Artificial Intelligence - Based Opportunistic Coronary Artery Calcium Scoring on Routine Chest-CT Scan
DisTal Arterio-Venous Fistula Feasibility
Impact of Bevel Orientation on Arteriovenous Fistula Puncture in Hemodialysis
IMPACT OF DIALYSIS DURATION AND DIURESIS ON BLADDER CAPACITY AND COMPLIANCE IN END STAGE RENAL DISEASE PATIENTS AWAITING RENAL TRANSPLANT
Effect of Amplifi Vein Dilation System Treatment on Radiocephalic AVF Maturation-3
Evaluation of the Effectiveness of a Mobile Application Developed for Hemodialysis Patients.
To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in ESRD Dialysis Patients
Inferior Vena Cava Collapsibility Index and Intradialytic Hypotension
Predictive Value of Carotid Ultrasonography for Intradialytic Hypotension
Pleth Variability Index for Predicting Low Blood Pressure During Maintenance Hemodialysis
Hemodialysis-Induced Renal Perfusion Decline: Unraveling the Pathophysiological Mechanisms Linking Intradialytic Circulatory Stress to Residual Renal Function Loss
BONE ANCHORED PORT for Hemodialysis Treatment